Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars

Identifieur interne : 000408 ( PascalFrancis/Curation ); précédent : 000407; suivant : 000409

Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars

Auteurs : Alessandra Carattoli [Italie] ; Paola Di Bonito [Italie] ; Felicia Grasso [Italie] ; Colomba Giorgi [Italie] ; Francesco Blasi [Italie] ; Matthias Niedrig [Allemagne] ; Antonio Cassone [Italie]

Source :

RBID : Pascal:05-0484475

Descripteurs français

English descriptors

Abstract

A new Coronavirus (SARS-CoV) is the aetiological agent of the severe acute respiratory syndrome (SARS). Because of the critical role played by serological assays for SARS diagnosis, an in-house ELISA based on SARS-CoV recombinant antigens was developed. The SARS-CoV nucleocapsid protein (N), three N fragments (N1, N2, and N3) and the intraviral domain of the membrane protein (M2) were cloned and expressed in Escherichia coli as histidine-tagged proteins. Six reference sera from SARS patients were used to detect virus-specific IgG in an ELISA using each recombinant protein as coating antigen. High-titre positive reactions were detected in all SARS positive sera. The specificity of the assay appears to be high as no positive reaction was detected in the sera of 20 healthy subjects and 73 patients with non-SARS, low-tract respiratory infections. Specific hyper-immune sera to SARS-CoV and the recombinant proteins, N, N1, N2, N3, and M2 were also generated in mice and rabbits. The specificity of these sera was confirmed by an immunocytochemical assay on biochips of SARS-CoV infected and uninfected cells.
pA  
A01 01  1    @0 0146-6615
A02 01      @0 JMVIDB
A03   1    @0 J. med. virol.
A05       @2 76
A06       @2 2
A08 01  1  ENG  @1 Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars
A11 01  1    @1 CARATTOLI (Alessandra)
A11 02  1    @1 DI BONITO (Paola)
A11 03  1    @1 GRASSO (Felicia)
A11 04  1    @1 GIORGI (Colomba)
A11 05  1    @1 BLASI (Francesco)
A11 06  1    @1 NIEDRIG (Matthias)
A11 07  1    @1 CASSONE (Antonio)
A14 01      @1 Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità @2 Rome @3 ITA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 7 aut.
A14 02      @1 Ospedale Maggiore Policlinico, University of Milan @2 Milan @3 ITA @Z 5 aut.
A14 03      @1 Robert Koch Institut @2 Berlin @3 DEU @Z 6 aut.
A20       @1 137-142
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 17422 @5 354000129811490010
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 17 ref.
A47 01  1    @0 05-0484475
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of medical virology
A66 01      @0 USA
C01 01    ENG  @0 A new Coronavirus (SARS-CoV) is the aetiological agent of the severe acute respiratory syndrome (SARS). Because of the critical role played by serological assays for SARS diagnosis, an in-house ELISA based on SARS-CoV recombinant antigens was developed. The SARS-CoV nucleocapsid protein (N), three N fragments (N1, N2, and N3) and the intraviral domain of the membrane protein (M2) were cloned and expressed in Escherichia coli as histidine-tagged proteins. Six reference sera from SARS patients were used to detect virus-specific IgG in an ELISA using each recombinant protein as coating antigen. High-titre positive reactions were detected in all SARS positive sera. The specificity of the assay appears to be high as no positive reaction was detected in the sera of 20 healthy subjects and 73 patients with non-SARS, low-tract respiratory infections. Specific hyper-immune sera to SARS-CoV and the recombinant proteins, N, N1, N2, N3, and M2 were also generated in mice and rabbits. The specificity of these sera was confirmed by an immunocytochemical assay on biochips of SARS-CoV infected and uninfected cells.
C02 01  X    @0 002A05C10
C02 02  X    @0 002B05C02J
C03 01  X  FRE  @0 Coronavirus @2 NW @5 01
C03 01  X  ENG  @0 Coronavirus @2 NW @5 01
C03 01  X  SPA  @0 Coronavirus @2 NW @5 01
C03 02  X  FRE  @0 Protéine recombinante @5 05
C03 02  X  ENG  @0 Recombinant protein @5 05
C03 02  X  SPA  @0 Proteína recombinante @5 05
C03 03  X  FRE  @0 Technique ELISA @5 06
C03 03  X  ENG  @0 ELISA assay @5 06
C03 03  X  SPA  @0 Técnica ELISA @5 06
C03 04  X  FRE  @0 Diagnostic @5 07
C03 04  X  ENG  @0 Diagnosis @5 07
C03 04  X  SPA  @0 Diagnóstico @5 07
C03 05  X  FRE  @0 Anticorps @5 08
C03 05  X  ENG  @0 Antibody @5 08
C03 05  X  SPA  @0 Anticuerpo @5 08
C03 06  X  FRE  @0 Sérologie @5 09
C03 06  X  ENG  @0 Serology @5 09
C03 06  X  SPA  @0 Serología @5 09
C03 07  X  FRE  @0 Syndrome respiratoire aigu sévère @2 NM @5 14
C03 07  X  ENG  @0 Severe acute respiratory syndrome @2 NM @5 14
C03 07  X  SPA  @0 Síndrome respiratorio agudo severo @2 NM @5 14
C07 01  X  FRE  @0 Coronaviridae @2 NW
C07 01  X  ENG  @0 Coronaviridae @2 NW
C07 01  X  SPA  @0 Coronaviridae @2 NW
C07 02  X  FRE  @0 Nidovirales @2 NW
C07 02  X  ENG  @0 Nidovirales @2 NW
C07 02  X  SPA  @0 Nidovirales @2 NW
C07 03  X  FRE  @0 Virus @2 NW
C07 03  X  ENG  @0 Virus @2 NW
C07 03  X  SPA  @0 Virus @2 NW
C07 04  X  FRE  @0 Appareil respiratoire pathologie @5 13
C07 04  X  ENG  @0 Respiratory disease @5 13
C07 04  X  SPA  @0 Aparato respiratorio patología @5 13
C07 05  X  FRE  @0 Virose
C07 05  X  ENG  @0 Viral disease
C07 05  X  SPA  @0 Virosis
C07 06  X  FRE  @0 Infection
C07 06  X  ENG  @0 Infection
C07 06  X  SPA  @0 Infección
C07 07  X  FRE  @0 Poumon pathologie @5 16
C07 07  X  ENG  @0 Lung disease @5 16
C07 07  X  SPA  @0 Pulmón patología @5 16
N21       @1 339

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:05-0484475

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars</title>
<author>
<name sortKey="Carattoli, Alessandra" sort="Carattoli, Alessandra" uniqKey="Carattoli A" first="Alessandra" last="Carattoli">Alessandra Carattoli</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Di Bonito, Paola" sort="Di Bonito, Paola" uniqKey="Di Bonito P" first="Paola" last="Di Bonito">Paola Di Bonito</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Grasso, Felicia" sort="Grasso, Felicia" uniqKey="Grasso F" first="Felicia" last="Grasso">Felicia Grasso</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Giorgi, Colomba" sort="Giorgi, Colomba" uniqKey="Giorgi C" first="Colomba" last="Giorgi">Colomba Giorgi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Blasi, Francesco" sort="Blasi, Francesco" uniqKey="Blasi F" first="Francesco" last="Blasi">Francesco Blasi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Ospedale Maggiore Policlinico, University of Milan</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Robert Koch Institut</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Cassone, Antonio" sort="Cassone, Antonio" uniqKey="Cassone A" first="Antonio" last="Cassone">Antonio Cassone</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0484475</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0484475 INIST</idno>
<idno type="RBID">Pascal:05-0484475</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000582</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000408</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars</title>
<author>
<name sortKey="Carattoli, Alessandra" sort="Carattoli, Alessandra" uniqKey="Carattoli A" first="Alessandra" last="Carattoli">Alessandra Carattoli</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Di Bonito, Paola" sort="Di Bonito, Paola" uniqKey="Di Bonito P" first="Paola" last="Di Bonito">Paola Di Bonito</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Grasso, Felicia" sort="Grasso, Felicia" uniqKey="Grasso F" first="Felicia" last="Grasso">Felicia Grasso</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Giorgi, Colomba" sort="Giorgi, Colomba" uniqKey="Giorgi C" first="Colomba" last="Giorgi">Colomba Giorgi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Blasi, Francesco" sort="Blasi, Francesco" uniqKey="Blasi F" first="Francesco" last="Blasi">Francesco Blasi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Ospedale Maggiore Policlinico, University of Milan</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Robert Koch Institut</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Cassone, Antonio" sort="Cassone, Antonio" uniqKey="Cassone A" first="Antonio" last="Cassone">Antonio Cassone</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of medical virology</title>
<title level="j" type="abbreviated">J. med. virol.</title>
<idno type="ISSN">0146-6615</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of medical virology</title>
<title level="j" type="abbreviated">J. med. virol.</title>
<idno type="ISSN">0146-6615</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibody</term>
<term>Coronavirus</term>
<term>Diagnosis</term>
<term>ELISA assay</term>
<term>Recombinant protein</term>
<term>Serology</term>
<term>Severe acute respiratory syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Coronavirus</term>
<term>Protéine recombinante</term>
<term>Technique ELISA</term>
<term>Diagnostic</term>
<term>Anticorps</term>
<term>Sérologie</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A new Coronavirus (SARS-CoV) is the aetiological agent of the severe acute respiratory syndrome (SARS). Because of the critical role played by serological assays for SARS diagnosis, an in-house ELISA based on SARS-CoV recombinant antigens was developed. The SARS-CoV nucleocapsid protein (N), three N fragments (N1, N2, and N3) and the intraviral domain of the membrane protein (M2) were cloned and expressed in Escherichia coli as histidine-tagged proteins. Six reference sera from SARS patients were used to detect virus-specific IgG in an ELISA using each recombinant protein as coating antigen. High-titre positive reactions were detected in all SARS positive sera. The specificity of the assay appears to be high as no positive reaction was detected in the sera of 20 healthy subjects and 73 patients with non-SARS, low-tract respiratory infections. Specific hyper-immune sera to SARS-CoV and the recombinant proteins, N, N1, N2, N3, and M2 were also generated in mice and rabbits. The specificity of these sera was confirmed by an immunocytochemical assay on biochips of SARS-CoV infected and uninfected cells.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0146-6615</s0>
</fA01>
<fA02 i1="01">
<s0>JMVIDB</s0>
</fA02>
<fA03 i2="1">
<s0>J. med. virol.</s0>
</fA03>
<fA05>
<s2>76</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CARATTOLI (Alessandra)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>DI BONITO (Paola)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>GRASSO (Felicia)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>GIORGI (Colomba)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BLASI (Francesco)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>NIEDRIG (Matthias)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>CASSONE (Antonio)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di Sanità</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Ospedale Maggiore Policlinico, University of Milan</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Robert Koch Institut</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20>
<s1>137-142</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>17422</s2>
<s5>354000129811490010</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>17 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0484475</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of medical virology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A new Coronavirus (SARS-CoV) is the aetiological agent of the severe acute respiratory syndrome (SARS). Because of the critical role played by serological assays for SARS diagnosis, an in-house ELISA based on SARS-CoV recombinant antigens was developed. The SARS-CoV nucleocapsid protein (N), three N fragments (N1, N2, and N3) and the intraviral domain of the membrane protein (M2) were cloned and expressed in Escherichia coli as histidine-tagged proteins. Six reference sera from SARS patients were used to detect virus-specific IgG in an ELISA using each recombinant protein as coating antigen. High-titre positive reactions were detected in all SARS positive sera. The specificity of the assay appears to be high as no positive reaction was detected in the sera of 20 healthy subjects and 73 patients with non-SARS, low-tract respiratory infections. Specific hyper-immune sera to SARS-CoV and the recombinant proteins, N, N1, N2, N3, and M2 were also generated in mice and rabbits. The specificity of these sera was confirmed by an immunocytochemical assay on biochips of SARS-CoV infected and uninfected cells.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A05C10</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B05C02J</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Protéine recombinante</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Recombinant protein</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Proteína recombinante</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Technique ELISA</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>ELISA assay</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Técnica ELISA</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Diagnostic</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Diagnosis</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Diagnóstico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Anticorps</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Antibody</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Anticuerpo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Sérologie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Serology</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Serología</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Appareil respiratoire pathologie</s0>
<s5>13</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Respiratory disease</s0>
<s5>13</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Aparato respiratorio patología</s0>
<s5>13</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Poumon pathologie</s0>
<s5>16</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Lung disease</s0>
<s5>16</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Pulmón patología</s0>
<s5>16</s5>
</fC07>
<fN21>
<s1>339</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000408 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000408 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0484475
   |texte=   Recombinant protein-based elisa and immuno-cytochemical assay for the diagnosis of sars
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021